Abstract
Purpose
The aim of this work was to optimize unidirectional buccal patches loaded with metoprolol (MT-MBPs) to provide adequate mucoadhesive and water uptake properties as well as controlled drug release for the effective treatment of different cardiovascular diseases.
Methods
The patches were prepared layer-by-layer using the solvent casting method. A central composite design was employed to statistically optimize the formulation variables. Chitosan and Pluronic® F-127 (poloxamer 407) concentrations were chosen as the independent variables, while ex vivo mucoadhesive force, ex vivo residence time, in vitro water uptake (%), and in vitro drug release (%) were to be considered the dependent variables. The optimized formulation was also characterized and evaluated in terms of morphology, thermal behavior, tensile strength, elongation at break, and ex vivo drug permeation.
Results
The optimized MT-MBPs were successful in terms of mucoadhesive force (3.58 ± 0.62 N), residence time (342.67 ± 17.21 min), and water uptake at 1 h (24.53 ± 3.62%). A controlled drug release was obtained for 8 h. Thermal and morphologic analyses demonstrated that metoprolol was homogeneously distributed throughout the microporous chitosan-based polymer matrix. Furthermore, the MT-MBPs exhibited a tensile strength of 3.76 ± 0.55 N/mm2 and an elongation at break of 36.52 ± 13.88%. The results of ex vivo permeation through pig buccal mucosa indicated that therapeutic metoprolol concentrations can be reached by using a patch of 5.62 cm2.
Conclusions
Optimal composition of the MT-MBPs included 2.9% (w/v) and 2.6% (w/v) of chitosan and Pluronic® F-127, respectively, which constitutes the most suitable makeup for metoprolol buccal delivery.
Similar content being viewed by others
Abbreviations
- MT:
-
metoprolol tartrate
MBPs
mucoadhesive buccal patches
MT-MBPs
mucoadhesive buccal patches loaded with metoprolol
CS
chitosan
PF-127
Pluronic® F-127
EC
ethyl cellulose
Eu-E100
Eudragit® E-100
RSM
response surface methodology
CCD
central composite design
SEM
scanning electron microscopy
DSC
differential scanning calorimetry
SSF
simulated salivary fluid
ANOVA
analysis of variance
References
Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release. 2011;153:106–16.
Hearnden V, Sankar V, Hull K, Juras DV, Greenberg M, Kerr AR, et al. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev. 2012;64:16–28.
Smart JD. Buccal drug delivery. Expert Opin Drug Deliv. 2005;2:507–17.
Ikeuchi-Takahashi Y, Ishihara C, Onishi H. Evaluation of polyvinyl alcohols as mucoadhesive polymers for mucoadhesive buccal tablets prepared by direct compression. Drug Dev Ind Pharm. 2017;43:1489–500.
Cevher E, Taha MA, Orlu M, et al. Evaluation of mechanical and mucoadhesive properties of clomiphene citrate gels formulations containing carbomers and their thiolated derivatives. Drug Deliv. 2008;15:57–67.
Kumria R, Al-Dhubiab BE, Shah J, et al. Formulation and evaluation of chitosan-based buccal bioadhesive films of zolmitriptan. J Pharm Innov. 2018;13:133–43.
Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm. 2011;77:187–99.
Kumria R, Nair AB, Goomber G, Gupta S. Buccal films of prednisolone with enhanced bioavailability. Drug Deliv. 2016;23:471–8.
Mati-Baouche N, Pierre-Henri E, Baynast H, et al. Chitosan as an adhesive. Eur Polym J. 2014;60:198–212.
Pitto-Barry A, Barry NPE. Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalization and clinical advances. Polym Chem. 2014;10:2381–496.
Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23:2709–28.
Abou el ela ael S, Allam AA, Ibrahim EH. Pharmacokinetics and anti-hypertensive effect of metoprolol tartrate rectal delivery system. Drug Deliv. 2016;23:69–78.
Ripley TL, Saseen JJ. β-Blockers: a review of their pharmacological and physiological diversity in hypertension. Ann Pharmacother. 2014;48:723–33.
Grassi G. Metoprolol in the treatment of cardiovascular disease: a critical reappraisal. Curr Med Res Opin. 2018;34:1635–43.
Fernandes GJ, Rathnanand M. J Pharm Innov. Formulation optimization for gastroretentive drug
Abul Kalam M, Khan AA, Khan S, Almalik A, Alshamsan A. Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box–Behnken experimental design. Int J Biol Macromol. 2016;87:329–40.
Parhi R, Panchamukhy T. RSM-based design and optimization of transdermal film of ondasteron HCl. J Pharm Innov. 2019. https://doi.org/10.1007/s12247-019-09373-9.
Box GPE, Wilson KB. On the experimental attainment of optimum conditions. J Roy Stat Soc Ser B. 1951;13:1–45.
Escobar-Chávez JJ, Merino V, Diez-Sales O, et al. Transdermal nortriptyline hydrochloride patch formulated within a chitosan matrix intended to be used for smoking cessation. Pharm Dev Technol. 2011;16:162–9.
Patel VF, Liu F, Brown MB. Modeling the oral cavity: in vitro and in vivo evaluations of buccal drug delivery systems. J Control Release. 2012;161:746–56.
Perioli L, Ambrogi V, Angelici F, Ricci M, Giovagnoli S, Capuccella M, et al. Development of mucoadhesive patches for buccal administration of ibuprofen. J Control Release. 2004;99:73–82.
El-Fek GS, Farouk Abdulmaguid R, Zayed GM, et al. Mucosal co-delivery of ketorolac and lidocaine using polymeric wafers for dental application. Drug Deliv. 2018;25:35–42.
Shiledar RR, Tagalpallewar AA, Kokare CR. Formulation and in vitro evaluation of xanthan gum-based bilayered mucoadhesive buccal patches of zolmitriptan. Carbohydr Polym. 2014;101:1234–42.
Nair AB, Kumria R, Harsha S, Attimarad M, al-Dhubiab BE, Alhaider IA. In vitro techniques to evaluate buccal films. J Control Release. 2013;166:10–21.
Adhikari SN, Nayak BS, Nayak AK, et al. Formulation and evaluation of buccal patches for delivery of atenolol. AAPS PharmSciTech. 2010;11:1038–44.
Yildiz Pekoz A, Sedef Erdal M, Okyar A, Ocak M, Tekeli F, Kaptan E, et al. Preparation and in-vivo evaluation of dimenhydrinate buccal mucoadhesive films with enhanced bioavailability. Drug Dev Ind Pharm. 2016;42:916–25.
Samson G, de la García Calera A, Dupuis-Girod S, et al. Ex vivo study of bevacizumab transport through porcine nasal mucosa. Eur J Pharm Biopharm. 2012;80:465–9.
Huang Y, Leobandung W, Fross A, et al. Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J Control Rellease. 2000;65:63–71.
Khutoryanskiy VV. Advances in mucoadhesion and mucoadhesive polymers. Macromol Biosci. 2011;11:748–64.
Shidhaye SS, Saindane NS, Sutar S, Kadam V. Mucoadhesive bilayered patches for administration of sumatriptan succinate. AAPS PharmSciTech. 2008;9:909–16.
Escobar-Chávez JJ, López-Cervantes M, Naïk A, et al. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci. 2006;9:339–58.
Siepmman J, Peppas NA. Higuchi equation: derivation, applications, use and misuse. Int J Pharm. 2011;418:6–12.
Gurny R, Doelker E, Peppas NA. Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers. Biomaterials. 1982;3:27–32.
Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
Varshosaz J, Faghihian H, Rastgoo K. Preparation and characterization of metoprolol controlled-release solid dispersions. Drug Deliv. 2006;13:295–302.
Helmy AM, Elsabahy M, Soliman GM, et al. Development and in vivo evaluation of chitosan beads for the colonic delivery of azathioprine for treatment of inflammatory bowel disease. Eur J Pharm Sci. 2017;109:269–79.
Mendosa NS, Murthy SN, Hashemnejad SM, et al. Development of poloxamer gel formulations via hot-melt extrusion technology. Int J Pharm. 2018;537:122–31.
Palem CR, Gannu R, Doodipala N, Yamsani VV, Yamsani MR. Transmucosal delivery of domperidone from bilayered buccal patches: in vitro, ex vivo and in vivo characterization. Arch Pharm Res. 2011;34:1701–10.
Lim H, Hoag SW. Plasticizer effects on physical-mechanicals properties of solvent cast Soluplus® films. AAPS PharmSciTech. 2013;14:903–10.
Senel S, Kremer MJ, Kaş S, et al. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials. 2000;21:2067–71.
Bernkop-Schnürch A, Dünnhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 2012;81:463–79.
Seelig A, Gerebtzoff G. Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding. Expert Opin Drug Metab Toxicol. 2006;2:733–52.
Acknowledgments
Dr. Escobar Chávez wants to acknowledge PAPIIT IT/UNAM [200218]; Cátedra PIAPI [1817]; and PIAPIME [2.12.27.19].
Availability of Data and Materials
All data generated or analyzed in this study are included in this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Escalona-Rayo, C.F., Serrano-Castañeda, P., López-Cervantes, M. et al. Optimization of Unidirectional Mucoadhesive Buccal Patches Based on Chitosan and Pluronic® F-127 for Metoprolol Controlled Release: In Vitro and Ex Vivo Evaluations. J Pharm Innov 15, 556–568 (2020). https://doi.org/10.1007/s12247-019-09401-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12247-019-09401-8